Wilson has 20+ years of experience in high-throughput bioanalytical mass spectrometry in various areas of drug discovery and development. He is currently a Scientific Director in the Leads Discovery and Optimization (LDO) department at Bristol Myers Squibb in Princeton, NJ, where he oversees a team providing in vitro ADME profiling and high-throughput mass spectrometry support for hit generation, hit to lead, and lead optimization efforts. Wilson received his B.S. in Chemistry from Fudan University, and his Ph.D. in Analytical Chemistry from Georgia Institute of Technology.